Globus Medical Inc. (GMED)
undefined
undefined%
At close: undefined
82.42
0.11%
After-hours Dec 13, 2024, 04:00 PM EST

Company Description

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally.

It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives.

The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants.

In addition, it distributes human cell, tissue, and cellular and tissue-based products.

Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

Globus Medical Inc.
Globus Medical Inc. logo
Country United States
IPO Date Aug 3, 2012
Industry Medical - Devices
Sector Healthcare
Employees 5,000
CEO Daniel T. Scavilla

Contact Details

Address:
2560 General Armistead Avenue
Audubon, Pennsylvania
United States
Website https://www.globusmedical.com

Stock Details

Ticker Symbol GMED
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001237831
CUSIP Number 379577208
ISIN Number US3795772082
Employer ID 04-3744954
SIC Code 3841

Key Executives

Name Position
Daniel T. Scavilla President, Chief Executive Officer & Director
Keith W. Pfeil Chief Financial Officer & Chief Operating Officer
Brian J. Kearns Senior Vice President of Business Development & Investor Relations
David C. Paul Co-Founder & Executive Chairman
Kelly G. Huller Esq. Senior Vice President, General Counsel & Secretary

Latest SEC Filings

Date Type Title
Dec 04, 2024 4 Filing
Nov 25, 2024 4 Filing
Nov 25, 2024 4 Filing
Nov 25, 2024 4 Filing
Nov 20, 2024 4 Filing
Nov 14, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Nov 08, 2024 4 Filing
Nov 08, 2024 4 Filing
Nov 05, 2024 10-Q Quarterly Report
Nov 05, 2024 8-K Current Report